Evidence map›Paper›PMID 31628728›Full record

ArticleJournal of thrombosis and haemostasis : JTH2020

Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation.

Andrew D Meyer, Anjana R Rishmawi, Robin Kamucheka, Crystal Lafleur, Andriy I Batchinsky, Nigel Mackman, Andrew P Cap

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06938217 (Safety and Efficacy of Low-Flow ECMO in a Multi-modal Cohort of Adults in Respiratory Failure), which is not on this map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06938217 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Safety and Efficacy of Low-Flow ECMO in a Multi-modal Cohort of Adults in Respiratory Failure

TypeinterventionalSponsorInstitute for Extracorporeal Life SupportRan2025 to 2027Enrolled30ConditionsAcute Hypoxemic Respiratory Failure, Mechanical Ventilation, Acute Respiratory Distress Syndrome (ARDS)ArmsLow-flow ECMO
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Management of Bleeding and Thrombotic Complications During Pediatric Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2024
    Pooled it
  3. Exercise and Circulating Microparticles in Healthy Subjects.Journal of cardiovascular translational research · 2021
    Pooled it
  4. Article
  5. Considerations and future challenges in managing ECMO for pediatric patients.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026
    Review
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Clinical use of thrombin generation assays.Journal of thrombosis and haemostasis : JTH · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrew D MeyerDivision of Pediatric Critical Care, Department of Pediatrics, University of Texas Health, San Antonio, Texas.ORCID 0000-0001-8121-2619
Anjana R RishmawiDivision of Pediatric Critical Care, Department of Pediatrics, University of Texas Health, San Antonio, Texas.
Robin KamuchekaCoagulation and Blood Research, U.S. Army Institute of Surgical Research (USAISR), Ft. Sam Houston, Texas.
Crystal LafleurCoagulation and Blood Research, U.S. Army Institute of Surgical Research (USAISR), Ft. Sam Houston, Texas.
Andriy I BatchinskyExtracorporeal Life Support, U.S. Army Institute of Surgical Research (USAISR), Ft. Sam Houston, Texas.
Nigel MackmanThrombosis and Hemostasis Program, Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Andrew P CapCoagulation and Blood Research, U.S. Army Institute of Surgical Research (USAISR), Ft. Sam Houston, Texas.
United States Army Institute of Surgical Research · USThe University of Texas Health Science Center at San Antonio · USUniversity of North Carolina at Chapel Hill · US

Funding

Pro-thrombotic Microparticles Generated by Pediatric Cardiopulmonary BypassK23HL124336 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MEYER, ANDREW DUNCAN JOSEPH · 2015 to 2018
$725k
NHLBI NIH HHS K23 HL124336
6 · The paper itself

Abstract

backgroundExtracorporeal membrane oxygenation (ECMO) has frequent and sometimes lethal thrombotic complications. The role that activated platelets, leukocytes, and small (0.3-micron to 1-micron) extracellular vesicles (EVs) play in ECMO thrombosis is not well understood.

objectivesTo test the effect of blood flow rate on the generation of activated platelets, leukocytes, and EVs in a simulated neonatal ECMO circuit using heparinized human whole blood.

methodsSimulated neonatal roller pump circuits circulated whole blood at low, nominal, and high flow rates (0.3, 0.5, and 0.7 L/min) for 6 h. Coagulopathy was defined by thromboelastography (TEG), STA

resultsDespite heparinization, occlusive thrombosis halted flow in two of five circuits at 0.3 L/min and three of five circuits at 0.7 L/min. None of the five circuits at 0.5 L/min exhibited occlusive thrombosis. Phosphatidylserine (PS)-positive platelets and EVs increased at all flow rates more than blood under static conditions (P < .0002). Tissue factor (TF)-positive leukocytes and EVs increased only in low-flow and high-flow circuits (P < .0001). Tissue factor pathway inhibitor (TFPI), at 50 times more than the concentration in healthy adults, failed to suppress thrombin initiation in low-flow and high-flow circuits.

conclusionsThis in vitro study informs ECMO specialists to avoid low and high blood flow that increases TF expression on leukocytes and EVs, which likely initiate clot formation. Interventions to decrease TF generated by ECMO may be an effective approach to decrease thrombosis.

Indexed as

Extracellular VesiclesThrombosisAdultBlood Coagulation TestsBlood PlateletsHumansInfant, NewbornLeukocytesblood cellsextracellular vesiclesextracorporeal membrane oxygenationthrombosistissue factor

Identifiers

PMID31628728
PMCPMC7350929
OpenAlexW2981133128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.